|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| C07K 16/24 | (2006.01) | ||
| C12N 15/63 | (2006.01) | ||
| C12N 15/10 | (2006.01) |
| (11) | Number of the document | 1839120 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05855447.8 |
| Date of filing the European patent application | 2005-12-21 | |
| (97) | Date of publication of the European application | 2007-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-23 |
| (46) | Date of publication of the claims translation | 2014-01-27 |
| (86) | Number | PCT/US2005/046885 |
| Date | 2005-12-21 |
| (87) | Number | WO 2006/071804 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 637936 P | 2004-12-21 | US |
| (72) |
LU, Jin, US
NESSPOR, Thomas, US
SCALLON, Bernard, US
SNYDER, Linda, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Vektoriai, ląstelės anti-IL-2 antikūnų pagrindu, jų gavimo būdai ir panaudojimas |
| ANTI-IL-12 ANTIBODY BASED VECTORS, HOST CELLS, AND METHODS OF PRODUCTION AND USES |
| Payment date | Validity (years) | Amount | |
| 2023-11-30 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-12-21 |